Keywords: Drug discovery


OpenAI unveils GPT-Rosalind to accelerate life sciences research

OpenAI has introduced GPT-Rosalind, a reasoning model designed for life sciences research, marking the company’s first major move into scientific AI tools focused on genomics, drug discovery, and protein engineering. The release came alongside a broad update to its Codex coding agent, which gained......

Harvard AI decoder cuts quantum computing errors by up to 17 times

A series of recent breakthroughs highlights the growing convergence between quantum computing and artificial intelligence in pharmaceutical research, with major contributions from Harvard University, IBM, and Cleveland Clinic. On April 10, researchers at Harvard University unveiled “Cascade,”......

Artificial intelligence tools accelerate drug and protein research breakthroughs

A new generation of artificial intelligence tools is transforming biomedical research, enabling scientists to analyze genetic regulation, decode protein structures, and design drug compounds in a fraction of the time previously required. Recent studies show that machine learning systems can compress......